Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00135473
Recruitment Status : Completed
First Posted : August 26, 2005
Last Update Posted : February 11, 2016
German Federal Ministry of Education and Research
B. Braun Melsungen AG
Novo Nordisk A/S
HemoCue Gmbh, Großostheim, Germany
Information provided by:
German Competence Network Sepsis